London, United Kingdom–(Newsfile Corp. – June 1, 2026) – Edison issues report on Nabaltec (XETRA: NTG).
Nabaltec is a German specialist chemicals business focused on aluminium hydroxide- and aluminium oxide-based products. Its products are used where customers require fire safety, smoke suppression, thermal management, electrical insulation and wear resistance. The company’s largest segment, Functional Fillers, supplies halogen-free flame-retardant fillers, fine hydroxides, viscosity-optimised hydrates and boehmites for applications including power and data cables, EV charging infrastructure, battery thermal management and separator coatings. Specialty Aluminas supplies aluminium oxide-based products into refractory, technical ceramics, polishing, catalyst and electrical insulation applications.
Click here to read the full report.
All reports published by Edison are available to download free of charge from its website.
www.edisongroup.com
Edison is authorised and regulated by the Financial Conduct Authority.
Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.
Connect with Edison on:
LinkedIn www.linkedin.com/company/edison-group-/
X www.x.com/edison_inv_res
YouTube www.youtube.com/edisonitv
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299627
Synergy Disc® presentation showcased statistically superior IDE trial outcomes, restoration of cervical lordosis, and long-term…
Presentation explored motion-restoring alternatives for select patients with persistent pain or pseudoarthrosis following cervical fusion…
WHO identifies rVSV-based candidate as a top priority amid growing Ebola epidemic with no approved…
Company highlights streamlined body-map tracking and image management features designed to support long-term skin monitoring…
SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB)…
SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB)…